News

Under the agreement, Teva would be using the Codexis process for key process steps in the manufacture of this product, assuming technical milestones are met. Financial terms were

“This is yet another important step in Rosetta Genomics’ commercialization efforts,” noted Ronen Tamir, Chief Commercialization Officer at Rosetta Genomics. “As Israel provided its citizens with health insurance

Ms Grahn was most recently vice president of clinical operations at MedGenesis Therapeutix. At Horizon, Ms Grahn will lead all clinical operations activities. Ms Grahn has a master’s

Mr McCoy will continue to serve on the board as a director. Mr Edgerton has served on the company’s board of directors since February 2007. Mr Edgerton spent

Under the terms of the agreement, Warner Chilcott has exclusive US rights to develop and market the product for the treatment of erectile dysfunction (ED). Dong-A will receive

The collaboration is expected to be focused on improving data analysis and interpretation of high content screening, an enabling technology in the search for key cellular markers associated with human

Valeant develops and markets prescription and nonprescription pharmaceutical products. Valeant specializes in the neurology and dermatology therapeutic areas primarily in the US, Canada, Mexico, Brazil, Australia, and Central

As of the expiration of the tender offer, a total of approximately 73.17 shares of Memory common stock were tendered and not withdrawn, representing approximately 89% of outstanding

This candidate drug is a small molecule that Galapagos has developed in its selective androgen receptor modulator program and which has demonstrated successful proof of concept in animal